Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors

Autor: Hyder, Mustafa A., Goebel, W. Scott, Ervin, Kirsten D., Schwartz, Jennifer E., Robertson, Michael J., Thakrar, Teresa C., Albany, Costantine, Farag, Sherif S. *
Zdroj: In Biology of Blood and Marrow Transplantation July 2018 24(7):1497-1504
Databáze: ScienceDirect
Externí odkaz: